Neutrophil inhibitory factor (NIF) is a recently cloned 41-kDa protein
from the canine hookworm that binds CD11b/CD18 and inhibits CD11b/CD1
8-dependent neutrophil adhesion. We evaluated NIF's effects on neutrop
hil-dependent lung injury in guinea pigs. Pulmonary vascular endotheli
al CD54 (ICAM-1) was induced in buffer-perfused lungs by 90-min exposu
re to 1000 U/ml TNF-alpha. Human neutrophils (2 x 10(7)) were added to
the perfusate and activated by 5 x 10(-9) PMA; in some lungs, the neu
trophils were pretreated with NIF (100 nM) before their addition to th
e perfusate. Lung injury was assessed by wet:dry weight ratio, and neu
trophil uptake by lung myeloperoxidase (MPO) activity. HUVEC exposed t
o TNF-alpha for 90 min were assayed for neutrophil adhesion, and we co
mpared PMA-stimulated neutrophil adhesion to endothelial cells and fib
rinogen-coated plates, PMA-induced pulmonary edema (lung wet:dry ratio
increased from 8.8 +/- 0.7 to 18.8 +/- 4.4) was inhibited by NIF (10.
0 +/- 1.0), Lung MPO activity concomitantly decreased from 17.1 +/- 6.
1 to 8.7 +/- 1.8 U/mg dry lung tissue in the NIF-treated group, simila
r to controls (6.9 +/- 2.0). Endothelial monolayer experiments confirm
ed that NIF reduced neutrophil adherence (basal adhesion of 11 +/- 3%
increased to 30 +/- 5% with TNF-alpha pretreatment of endothelial cell
s, an increase that was reduced to 10 +/- 4% with NIF). Moreover, NIF
prevented PMA-induced neutrophil adhesion to fibrinogen, a CD11b/CD18-
dependent event, but produced a smaller decrease in adherence to endot
helial cells, which also involves CD11a/CD18 integrins. These studies
indicate that NIF prevents neutrophil-dependent lung vascular injury b
y inhibiting neutrophil adhesion to the TNF-alpha-activated endotheliu
m.